Stock listing

ARWR Stock Price, News, Filings & Events — Arrowhead Pharmaceuticals, Inc.

Selected listing: ARWR · BMV · MXN · MX

This page tracks Arrowhead Pharmaceuticals, Inc.'s ARWR:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARWR:BMV. ARWR:BMV is the stock-level entry point for investors researching Arrowhead Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arrowhead Pharmaceuticals, Inc. is a public company traded under the ticker ARWR in the American market. The company has a market capitalization of approximately $12.06 billion. Arrowhead focuses on developing innovative medicines using its proprietary RNA-targeted technology platform.

ARWR:BMVMXNMXUpdated August 14, 2026
Arrowhead Pharmaceuticals, Inc. logo
Ticker
ARWR:BMV
Asset type
Stock
Market cap
$12.24B
Sector
Health Technology
Industry
Biotechnology
Exchange
BMV
Currency
MXN

Arrowhead Pharmaceuticals, Inc. ARWR:BMV stock context

This page tracks Arrowhead Pharmaceuticals, Inc.'s ARWR:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARWR:BMV. ARWR:BMV is the stock-level entry point for investors researching Arrowhead Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arrowhead Pharmaceuticals, Inc. is a public company traded under the ticker ARWR in the American market. The company has a market capitalization of approximately $12.06 billion. Arrowhead focuses on developing innovative medicines using its proprietary RNA-targeted technology platform.

Research Arrowhead Pharmaceuticals, Inc.

Alternate listings